elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28252207-1A41BD71-BF0D-4966-AF89-5B899CD7B4C1
Q28252207-1A41BD71-BF0D-4966-AF89-5B899CD7B4C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-1A41BD71-BF0D-4966-AF89-5B899CD7B4C1
Risks and benefits of infliximab for the treatment of Crohn's disease
P1476
Q28252207-1A41BD71-BF0D-4966-AF89-5B899CD7B4C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28252207-1A41BD71-BF0D-4966-AF89-5B899CD7B4C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
58660efd1d48394ce5568d0d2680f00c3696d4f3
P1476
Risks and benefits of infliximab for the treatment of Crohn's disease
@en